MiniMed Group Inc (NASDAQ:MMED – Get Free Report) shares gapped up before the market opened on Monday. The stock had previously closed at $17.99, but opened at $18.83. MiniMed Group shares last traded at $18.7430, with a volume of 1,355,346 shares trading hands.
Analyst Upgrades and Downgrades
Several equities research analysts have weighed in on the company. Barclays cut their target price on MiniMed Group from $22.00 to $20.00 and set an “equal weight” rating for the company in a research note on Friday. Citigroup lifted their price target on MiniMed Group from $23.00 to $26.00 and gave the company a “buy” rating in a research note on Wednesday, September 2nd. Rothschild & Co Redburn initiated coverage on MiniMed Group in a research report on Tuesday, October 13th. They set a “buy” rating and a $30.00 price objective for the company. Weiss Ratings raised MiniMed Group from a “sell (d-)” rating to a “sell (d)” rating in a research note on Wednesday, September 9th. Finally, Mizuho raised their price objective on MiniMed Group from $26.00 to $28.00 and gave the company an “outperform” rating in a research note on Thursday, October 8th. Fourteen research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.12.
Get Our Latest Stock Report on MMED
MiniMed Group Price Performance
The firm’s fifty day moving average price is $19.61 and its 200-day moving average price is $16.73. The company has a market capitalization of $5.27 billion and a price-to-earnings ratio of -27.47.
Hedge Funds Weigh In On MiniMed Group
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Jump Financial LLC acquired a new position in shares of MiniMed Group in the third quarter valued at approximately $1,980,000. Marshall Wace LLP acquired a new stake in MiniMed Group during the 3rd quarter worth approximately $9,151,000. Healthcare of Ontario Pension Plan Trust Fund boosted its position in MiniMed Group by 358.7% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,720,000 shares of the company’s stock worth $33,488,000 after buying an additional 1,345,000 shares during the period. First Trust Advisors LP grew its holdings in MiniMed Group by 124.7% during the 3rd quarter. First Trust Advisors LP now owns 822,845 shares of the company’s stock worth $16,021,000 after acquiring an additional 456,577 shares during the last quarter. Finally, State Street Corp grew its holdings in MiniMed Group by 73.0% during the 3rd quarter. State Street Corp now owns 697,580 shares of the company’s stock worth $13,582,000 after acquiring an additional 294,291 shares during the last quarter.
About MiniMed Group
MiniMed Group focuses on diabetes technology, developing products and services to help people manage insulin-dependent diabetes. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets and software for tracking glucose and coordinating insulin delivery. The business is known for automated insulin-delivery systems that use glucose readings to help adjust insulin delivery, including products in the MiniMed 780G system line. Its technologies are intended for use by people with diabetes and the clinicians who support their care.
Recommended Stories
- Five stocks we like better than MiniMed Group
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
- Could Big Buybacks Be the Next Catalyst for These 3 AI Stocks?
- 3 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?
Receive News & Ratings for MiniMed Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiniMed Group and related companies with MarketBeat.com's FREE daily email newsletter.
